Caricamento...
Synthesis and Biological Evaluation of a Peptide Paclitaxel Conjugate Which Targets the Integrin α(v)β(6)
The integrin α(v)β(6) is an emergent biomarker for non-small cell lung cancer (NSCLC) as well as other carcinomas. We previously developed a tetrameric peptide, referred to as H2009.1, which binds α(v)β(6) and displays minimal affinity for other RGD-binding integrins. Here we report the use of this...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3195361/ https://ncbi.nlm.nih.gov/pubmed/21868241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2011.07.046 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|